Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
Tickers ALLK GILD GRFS IBB
Tags PFE Benzinga FDA
From Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of GDP Report
Tickers AIR BB CTAS DRI
Tags NVS Earnings Pre/Market Outlook
From Benzinga
Novartis Inks Option Agreement For BeiGene Anti-Cancer Therapy For Over $1B
Tickers BGNE NVS
Tags Health Care Contracts Biotech
From Benzinga
Novartis' Ligelizumab Suffers Setback In Late-Stage Skin Disorder Studies
Tickers NVS
Tags Market News Benzinga Trading Ideas
From Benzinga
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
Tickers ACRDF AFCG ARNA BBRRF
Tags AFCG marijuana Cannabis
From Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
Tickers ASRT ATRS BIIB CALT
Tags IBB VRCA SNDX
From Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
Tickers NVS RHHBF RHHBY RHHVF
Tags Benzinga Trading Ideas Market News
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Tickers ADGI ALZN BFRI BGNE
Tags MESO MIND NVS
From InvestorPlace
Could This Soaring Biotech Stock Make You Rich?
Tickers BLUE KRYS NVS
Tags Recent Press Releases BLUE NVS
From Motley Fool
Molecular Partners Inks License Deal With Novartis For $580M
Tickers MOLN NVS
Tags MOLN Briefs why it's moving
From Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
Tickers APTO ATRA AZN BLU
Tags Offerings Small Cap Biotech
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Tickers ALZN APTO ATRA BOIL
Tags DDL RTOKY Today's Market
From InvestorPlace
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
Tickers ARNA AVCNF JAZZ JNJ
Tags AVCNF Pfizer enters cannabis industry Market News
From Benzinga
7 CEOs That Ought to Follow Jack Dorsey Out the Door
Tickers ATVI CAG CCL FIS
Tags CCL Market News LW
From InvestorPlace
Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients
Tickers NVS REGN
Tags Benzinga Market News Diabetic Macular Edema
From Benzinga
Novartis' New Kisqali Data Shows Consistent Overall Survival Benefit Across Metastatic Breast Cancer Settings
Tickers NVS
Tags breast cancer Market News Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
Tickers AAL AAPL ACEL AMGN
Tags NVRO Initiation TBLA
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
Tickers ABBV ADCT AGIO ALNY
Tags ZYME CNTX News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021
Tickers ACEL AFL AGIO ALHC
Tags PNM SFIX Analyst Ratings
From Benzinga
Why Aurinia Pharmaceuticals Stock Bolted Higher Today
Tickers AUPH NVS
Tags Recent Press Releases Market News NVS
From Motley Fool
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Tickers ALPMF ALPMY NVS RHHBF
Tags RHHVF RHHBF Movers
From Benzinga
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today
Tickers AI AUPH BMY GSK
Tags GSK Today's Market NVS
From InvestorPlace
Breakthrough Cancer Therapy? This Biotech Shares Preclinical Data and Ambitious Plans
Tickers AZN NVS PFE
Tags NVS Partner Content AZN
From Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
Tickers ACST AMGN BNTX CMMB
Tags FDA BNTX ACST
From Benzinga
7 Drug Stocks to Buy Now While They’re Still on Sale
Tickers AMGN AZN BMY HZNP
Tags PG HZNP NVS
From InvestorPlace
Molecular Partners Says Its COVID-19 Antiviral Still Effective Against Positions Mutated In Omicron
Tickers MOLN NVS
Tags Biotech Small Cap Health Care
From Benzinga
3 Pharma Stocks That Are Too Cheap to Ignore
Tickers BMY NVS VTRS
Tags NVS Market News Recent Press Releases
From Motley Fool
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
Tickers BNTX JNJ MRK NVS
Tags MRK Market News PFE
From Benzinga
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
Tickers ALNY ARWR DRNA JNJ
Tags NVS DRNA Recent Press Releases
From Motley Fool
1 Cancer Stock on Buyout Watch in 2022
Tickers AMGN AZN BIIB BMY
Tags GILD Market News NVO
From Motley Fool
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.